SIGN UP

Stay informed of the latest progress in canine health research.

DONATE

We need your support to fund research that helps dogs live longer, healthier lives.

 

Donate Today

Canine Cancer Patient Biospecimens Now Available for Scientific Study

10/29/2012

Canine Comparative Oncology and Genomics Consortium and the Pfizer-CCOGC Biospecimen Repository Announce the Availability of Canine Cancer Patient Biospecimens for Scientific Study Effective October 29th 2012

Contact: Matthew Breen, Ph.D.
E-mail: Biospecimens@ccogc.net
Phone: 919-879-8438

Rockville, MD - Canine cancer patient biospecimens are now available for scientific use through the Canine Comparative Oncology and Genomics Consortium (CCOGC) and the Pfizer-CCOGC Biospecimen Repository.

The CCOGC has created an infrastructure for the collection and banking of tissues from dogs with naturally occurring cancer to help researchers further the investigation into the inner workings of cancer in the domestic dog, as well as facilitate investigation into tumor types with broad translational relevance that can benefit both human and dog patients.

The Pfizer-CCOGC Biospecimen Repository currently houses over 2,000 patient samples across seven spontaneously arising cancer histologies: osteosarcoma, lymphoma, melanoma, pulmonary tumors, mast cell tumor, soft tissue sarcomas and hemangiosarcoma. Samples available from each patient include: tumor and normal tissues (formalin fixed, snap frozen and OCT), as well as frozen serum, plasma, urine and whole blood (from both EDTA and PaxGene RNA collection tubes).

For more information about CCOGC and to apply for samples from the biorepository, please visit www.ccogc.net or contact us at biospecimens@ccogc.net.

CCOGC Background

Formed in 2004, the Canine Comparative Oncology and Genomics Consortium (CCOGC) is a group of veterinary and human medical and radiation oncologists, pathologists, surgeons, geneticists, and cellular and molecular biologists who share the common goals of facilitating collaborations across disciplines, focusing on the problem of cancer in dogs. Priorities of the CCOGC include advocacy for the field of Comparative Oncology, expansion of available canine-specific research reagents, and the development of a biospecimen repository.

With a lead gift from Pfizer Animal Health and substantial donations from the AKC Canine Health Foundation and Morris Animal Foundation, sample collection began in 2007. Standard operating procedures for tissue/sample collection and storage were established to maximize consistency and are subject to annual review. Informed owner consent and IACUC approval has been obtained prior to collection and samples have been de-identified at the collecting site. Each case in the repository is represented by tumor and normal tissue, collected and processed in ethanol and two frozen formats (flash frozen and OCT embedded). The repository follows many aspects of the organization and structure of the proposed National Biospecimen Network Blueprint. A sample shipping and collection database (Tissue Tracker) is used for real time connection between CCOGC collection sites and the central physical bank (Pfizer-CCOGC Biospecimen Repository) housed in Frederick, MD. Patient clinical information is contemporarily collected and logged as part of the biorepository effort and is available along with the samples.

In addition to providing access to banked canine cancer biospecimens, the CCOGC is also able to offer its tissue collection infrastructure to third parties who wish to request specific prospective collection of tissues. Further information may be obtained by contacting administration@ccogc.net.

For more information on the Canine Comparative Oncology and Genomics Consortium and the Pfizer-CCOGC Biospecimen Repository, please visit www.ccogc.net.

###

The Canine Comparative Oncology and Genomics Consortium (CCOGC) is a 501(c)3 non-for-profit. The goals of the CCOGC are to facilitate strategic partnerships and collaborations across a diversity of disciplines, focused on the problem of cancer in dogs. Priorities of the CCOGC include advocacy for the field of Comparative Oncology, the development of a mechanism to share reagents and resources in the community, and the development of a biospecimen repository. Visit CCOGC online at www.ccogc.net for more information.

  • Printer Friendly

Listen to the Latest Podcast

An Interview with Susan Lilly, New CEO of the AKC Canine Health Foundation

12/18/2014

In this podcast we hear from Susan Lilly, the new CEO of the AKC Canine Health Foundation. A native of Michigan, Susan boasts a strong fundraising background. After holding development positions at Central Michigan University, she served as Director of Development at Michigan State University and, most recently, was Executive Director of the North Carolina State University Veterinary Health Foundation. In this podcast Susan discusses her passion for helping animals, her enthusiasm about being a part of CHF and its mission, and her desire to connect with you and the many supporters of CHF.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, A KeyBank Trust.


Listen

Canines & Cocktails 2014

C&C 2014 banner ad 160x600